Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes mellitus. A perspective on management.

T J Merimee1

  • 1Department of Medicine, University of Florida College of Medicine, Gainesville.

The Journal of the Florida Medical Association
|November 1, 1991
PubMed
Summary

Achieving good blood sugar control in diabetes mellitus is crucial for preventing complications like blindness. Maintaining hemoglobin A1c levels below 8.4% significantly reduces the progression of retinopathy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study.

The Journal of clinical endocrinology and metabolism·1994
Same author

Growth hormone-binding protein levels: studies of children with short stature.

Metabolism: clinical and experimental·1994
Same author

Growth hormone-binding proteins of human serum: developmental patterns in normal man.

The Journal of clinical endocrinology and metabolism·1992
Same author

Hormone and receptor studies: relationship to linear growth in childhood and puberty.

The Journal of clinical endocrinology and metabolism·1991
Same author

The growth hormone-insulin-like growth factor I axis: studies in man during growth.

Advances in experimental medicine and biology·1991
Same author

Growth hormone-binding protein: II. Studies in pygmies and normal statured subjects.

The Journal of clinical endocrinology and metabolism·1990

Area of Science:

  • Endocrinology
  • Ophthalmology
  • Metabolic Diseases

Background:

  • Diabetes mellitus is a leading cause of preventable blindness in the US.
  • Diabetic complications, particularly retinopathy, pose a significant public health burden.
  • The link between glycemic control and diabetic complications is well-established.

Purpose of the Study:

  • To review the overwhelming evidence supporting intensive glycemic control in diabetes management.
  • To highlight the impact of hemoglobin A1c levels on diabetic retinopathy progression.
  • To explore reasons for physician resistance to optimal diabetes management strategies.

Main Methods:

  • Review of existing scientific literature and clinical data.
  • Analysis of studies correlating hemoglobin A1c levels with retinopathy progression.
  • Examination of physiological changes associated with euglycemia in diabetes.

Main Results:

  • Consistent glycemic control, aiming for near-normal blood glucose levels, dramatically reduces diabetic complications.
  • Hemoglobin A1c values consistently below 8.4% are associated with a significantly lower risk (2.9%) of retinopathy progression.
  • Higher hemoglobin A1c levels correlate with a progressive increase in the severity of retinopathy.
  • Biochemical, hemodynamic, and endocrine abnormalities in diabetes normalize with euglycemia.

Conclusions:

  • Intensive glycemic control is paramount in preventing diabetes-related blindness.
  • Maintaining optimal hemoglobin A1c levels is a key strategy for mitigating diabetic retinopathy.
  • Physician adherence to evidence-based diabetes management guidelines requires further attention.

Related Experiment Videos